Spectroscopic and Perfusion Magnetic Resonance Imaging Predictors of Progression in Pediatric Brain Tumors

Cancer

Volumn 100, Issue 6, 2004, Pages 1246-1256

  Tzika, A Aria ^a   Astrakas, Loukas G ^a   Zarifi, Maria K ^b   Zurakowski, David ^c   Poussaint, Tina Young ^c   Goumnerova, Liliana ^c   Tarbell, Nancy J ^a   Black, Peter McL ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Brain; Magnetic resonance; Neoplasms in infants and children; Spectroscopy

Indexed keywords

ADOLESCENT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EPENDYMOMA; FEMALE; GLIOMA; HUMAN; MALE; NEUROECTODERM TUMOR; NEUROIMAGING; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PINEAL BODY TUMOR; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

ADOLESCENT; ASPARTIC ACID; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHOLINE; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROGNOSIS;

EID: 1542314282     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20096     Document Type: Article

References (36)

1. Allen JC, Siffert J. Contemporary issues in the management of childhood brain tumors. Curr Opin Neurol. 1997;10:137-141.
2. Zimmerman RA. Past, present and future of pediatric neuroradiology. Childs Nerv Syst. 1999;15:624-634.
3. Fitz C. Magnetic resonance imaging of pediatric brain tumors [review]. Top Magn Reson Imaging. 1993;5:174-189.
4. Ashdown B, Boyko O, Uglieta J, et al. Postradiation cerebellar necrosis mimicking tumor: MR appearance. J Comput Assist Tomogr. 1993;17:124-126.
5. Bruggers C, Friedman H, Fuller G, et al. Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. Med Pediatr Oncol. 1993;21:301-306.
6. Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516-524.
7. Nelson SJ, Vigneron DB, Dillon WP. Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. NMR Biomed. 1999;12:123-138.
8. Tzika AA, Zurakowski D, Poussaint TY, et al. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology. 2001;43:169-177.
9. Usenius JP, Vainic P, Hernesniemi J, Kauppinen R. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem. 1994;63:1538-1543.
10. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg. 1996;84:449-458.
11. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;191:41-51.
12. Henry RG, Vigneron DB, Fischbein NJ, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol. 2000; 21:357-366.
13. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med. 1996;2:323-325.
14. Breslow N, Day N. Classical methods of analysis of grouped data. In: Breslow N, Day N. Statistical methods in cancer research, volume 1: the analysis of case-control studies. Lyon: International Agency for Research on Cancer, 1980:122-135.
15. Blythe CR. Approximate binomial confidence limits. J Am Stat Assoc. 1986;81:843-855.
16. Barker P, Breiter S, Soher B, et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med. 1994;32:157-163.
17. Miller BL, Chang L, Booth R, et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci. 1996; 58:1929-1935.
18. Gillies RJ, Barry JA, Ross BD. In vitro and in vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells. Magn Reson Med. 1994;32:310-318.
19. Shimizu H, Kumabe T, Shirane R, Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol. 2000;21:659-665.
20. Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology. 2000;42:333-338.
21. Cheng L, Anthony D, Comite A, Black P, Tzika A, Gonzalez R. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neurooncol. 2000;2:87-95.
22. Galons JP, Job C, Gillies RJ. Increase of GPC levels in cultured mammalian cells during acidosis. A 31P MR spectroscopy study using a continuous bioreactor system. Magn Reson Med. 1995;33:422-426.
23. Smith TA, Eccles S, Ormerod MG, Tombs AJ, Titley JC, Leach MO. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br J Cancer. 1991;64:821-826.
24. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
25. Hakumaki JM, Poptani H, Puumalainen AM, et al. Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res. 1998;58:3791-3799.
26. Nelson SJ, Huhn S, Vigneron DB, et al. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. J Magn Reson Imaging. 1997;7:1146-1152.
27. Graves EE, Nelson SJ, Vigneron DB, et al. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol. 2001;22:613-624.
28. Usenius T, Usenius JP, Tenhunen M, et al. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys. 1995;33:719-724.
29. Mahmood U, Alfieri AA, Thaler H, Cowburn D, Koutcher JA. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy. Cancer Res. 1994;54:4885-4691.
30. Bhakoo KK, Williams SR, Florian CL, Land H, Noble MD. Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res. 1996; 56:4630-4635.
31. Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg. 1997;87:525-534.
32. Lazareff JA, Bockhorst KH, Curran J, Olmstead C, Alger JR. Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery. 1998; 43:809-817; discussion, 817-818.
33. Siegal T, Rubinstein R, Tzuk-Shina T, Gomori JM. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg. 1997;86:22-27.
34. Folkman J. Tumor angiogenesis: a possible control point in tumor growth. Ann Intern Med. 1975;82:96-100.
35. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer. 1996;77:362-72.
36. Lund EL, Spang-Thomsen M, Skovgaard-Poulsen H, Kristjansen PE. Tumor angiogenesis-a new therapeutic target in gliomas. Acta Neurol Scand. 1998;97:52-62.